ORAL VERSUS VAGINAL SILDENAFIL IN REDUCING INTRA-PARTUM FETAL DISTRESS AND ENHANCEMENT OF NORMAL VAGINAL DELIVERY
Aboulenein, W., Abd Aldayem, T., Abd EL Aziz Ibrahim, T., Shouman, M. (2023). ORAL VERSUS VAGINAL SILDENAFIL IN REDUCING INTRA-PARTUM FETAL DISTRESS AND ENHANCEMENT OF NORMAL VAGINAL DELIVERY. EKB Journal Management System, 5(3), 32-33. doi: 10.21608/alexpo.2023.229053.1670
Wafaa Aboulenein; Tamer Abd Aldayem; Tamer Mohamed Abd EL Aziz Ibrahim; Magda Abdelfattah Hassan Shouman. "ORAL VERSUS VAGINAL SILDENAFIL IN REDUCING INTRA-PARTUM FETAL DISTRESS AND ENHANCEMENT OF NORMAL VAGINAL DELIVERY". EKB Journal Management System, 5, 3, 2023, 32-33. doi: 10.21608/alexpo.2023.229053.1670
Aboulenein, W., Abd Aldayem, T., Abd EL Aziz Ibrahim, T., Shouman, M. (2023). 'ORAL VERSUS VAGINAL SILDENAFIL IN REDUCING INTRA-PARTUM FETAL DISTRESS AND ENHANCEMENT OF NORMAL VAGINAL DELIVERY', EKB Journal Management System, 5(3), pp. 32-33. doi: 10.21608/alexpo.2023.229053.1670
Aboulenein, W., Abd Aldayem, T., Abd EL Aziz Ibrahim, T., Shouman, M. ORAL VERSUS VAGINAL SILDENAFIL IN REDUCING INTRA-PARTUM FETAL DISTRESS AND ENHANCEMENT OF NORMAL VAGINAL DELIVERY. EKB Journal Management System, 2023; 5(3): 32-33. doi: 10.21608/alexpo.2023.229053.1670

ORAL VERSUS VAGINAL SILDENAFIL IN REDUCING INTRA-PARTUM FETAL DISTRESS AND ENHANCEMENT OF NORMAL VAGINAL DELIVERY

ALEXMED ePosters
Article 1, Volume 5, Issue 3, September 2023, Page 32-33  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2023.229053.1670
View on SCiNiTO View on SCiNiTO
Authors
Wafaa Aboulenein1; Tamer Abd Aldayem2; Tamer Mohamed Abd EL Aziz Ibrahim3; Magda Abdelfattah Hassan Shouman email 4
1Obstetrics and Gynecology Department, Faculty of Medicine, Alexandria University, Egypt
2Obstetric and Gynecology department, faculty of Medicine, Alexandria University, Alexandria
3Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University
4Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University, Egypt.
Abstract
Normal vaginal delivery is defined as a low-risk pregnancy of spontaneous onset of labor taking place between 37 and 42 weeks' gestation, and it is the safest way for the fetus and the mother.
The force caused by the contractile myometrial bundles during labor causes reduction in blood flow with each contraction, as there is a reduction in the placental blood flow causing less efficient gas and nutrient exchange which is detected by the fetus stimulating an increase of heart rate as force getting stronger.
Sildenafil citrate (SC) is potent, selective, and is considered as reversible PDE5 inhibitor which is abundant in the Corpus Cavernosum of the penis and pulmonary arteries. It increases the NO action through PDE5 hindering, resulting in relaxation of smooth muscles and The work was designed to assess sildenafil citrate via different routes versus vaginal placebo to decrease caesarean deliveries due to intra-partum fetal distress depending on the hypothesis that entails that through its vasodilatory action and by increasing uterine and placental perfusion in labor, cervical dilation is enhanced through vasodilation which increases blood flow carrying prostaglandins and hormones acting on cervical tissues, causing more dilatation and effacement, improving myometrium performance which ultimately results in shortening time of delivery and decreasing fetal distress.
Keywords
SILDENAFIL; INTRA-PARTUM FETAL; DISTRESS
Supplementary Files
Statistics
Article View: 29